Work

In vivo imaging of CD8+T cells in patients with metastatic melanoma under immune checkpoint inhibitor therapy to detect treatment response and immune-related adverse events using [Zr-89]Zr-crefmirlimab berdoxam PET/CT

Year: 2025

Type: article

Source: Nuklearmedizin - NuclearMedicine

DOI: 10.1055/s-0045-1804288

Authors: J Schwenck, N Trautwein, T Amaral, D Sonanini, M Pritzkow, B Gückel, W Ehrlichmann, G Kienzle, K Schmiedehausen, I Wilson, W Le, G Smith, F Seith, A Forschner, M Röcken, G Reischl, B Pichler, M Kneilling, L Flatz, C la Fougère

Institutions: University of Tübingen, ImaginAb (United States), German Cancer Research Center, Deutsches Konsortium für Translationale Krebsforschung

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408348200

FWCI:

Cites:

Cited by:

Related to: 10